Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors
US6462042B1 · kind B1 · utility
1Cited by
1References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 28, 2001 |
| Grant date | Oct 8, 2002 |
| Priority date | — |
| Expiry date | Apr 4, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds having therapeutic utility are of formula (I) wherein B1, B2, R1 and R2 are each various sub-stituents, or R1 and R2 together form a ring.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.